Immune Checkpoint Inhibitor-Induced Fanconi Syndrome

Cureus
doi 10.7759/cureus.7686
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Cureus, Inc.

Related search

Immune Checkpoint Inhibitor Nephrotoxicity: Update 2020

Kidney360
2020English

In Reply — Immune Checkpoint Inhibitor–Induced Type 1 Diabetes: An Underestimated Risk

Mayo Clinic Proceedings
Medicine
2020English

Immune Checkpoint Inhibitor‐induced Type 1 Diabetes: A Systematic Review and Meta‐analysis

Diabetic Medicine
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

Tenosynovitis Induced by an Immune Checkpoint Inhibitor: A Case Report and Literature Review

Internal Medicine
Internal MedicineMedicine
2019English

Development of PARP and Immune-Checkpoint Inhibitor Combinations

Cancer Research
Cancer ResearchOncology
2018English

Osteomalacia Due to Drug-Induced Fanconi Syndrome

Arthritis and Rheumatology
RheumatologyAllergyImmunology
2018English

Hypokalemic Paralysis Secondary to Immune Checkpoint Inhibitor Therapy

Case Reports in Oncological Medicine
Oncology
2017English

Letter: Immune Checkpoint Inhibitor-Induced Colitis-Shouldn't We Be Checking More Often? Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2019English

Can an Immune Checkpoint Inhibitor (Sometimes) Make Things Worse?

Clinical Cancer Research
Cancer ResearchOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy